 |
Modified release/drug delivery: modifications should be based on pharmacokinetic
considerations ("target profile"), e.g. retardation to improve safety and
tolerability
|
 |
Modified gastro-intestinal transit: modifications may be advantageous in case of compounds
which are not absorbed consistently from all parts of the GI tract
|
 |
Therapy "adjusted" dosing regimen: adjustments seem useful e.g. in cases of diurnal
variation of symptoms or clinical effects
|